October 26, 2011
The past two days have been focused on The Physician Payment Sunshine provisions of the Patient Protection Affordable Care Act in the U.S. which will require the reporting of financial relationships between medical product manufacturers and medical providers by 2013. … Continue reading →
October 25, 2011
As noted yesterday, the Physician Payment Sunshine Act is now law, but so far, the deadline for Health and Human Services to provide guidance to medical product manufacturers on what exactly to report and how exactly to report it has … Continue reading →
March 1, 2011
You may have noticed that I have done my best to observe and track what is going on in pharma and social media from a utilization standpoint. In December of 2010, I posted another in what has been a series … Continue reading →
October 15, 2008
It continues to be a rather strikingly ironic observation that for some the pharmaceutical industry continues to be in the depths of public perceptions despite the fact that it is an industry that provides life and alleviates suffering to so … Continue reading →
August 25, 2008
It is poetic that following the close of the Olympics in Beijing – an event that went very well in spite of all the worries leading up to it – that Boehringer Ingelheim announces a cooperation deal with a Chinese … Continue reading →